Bartholin's gland benign neoplasm is a noncancerous growth that forms near the vaginal opening in the Bartholin’s gland. People with this condition may notice a painless lump, mild pressure with sitting, or discomfort during sex. It can persist or slowly enlarge over weeks to months, and it does not affect life expectancy. Bartholin's gland benign neoplasm is most often recognized in adults, and not everyone will have the same experience. Treatment often involves warm compresses, drainage, or minor surgery, and doctors sometimes remove the mass to confirm it is benign and relieve symptoms.
Overview
Bartholin's gland benign neoplasmSymptoms
Bartholin's gland benign neoplasm often appears as a painless lump near the vaginal opening. Early symptoms of Bartholin's gland benign neoplasm include swelling, pressure, or discomfort with walking, sitting, or sex. Some notice irritation or mild pain if it enlarges.
Outlook and prognosis
Most Bartholin’s gland benign neoplasms grow slowly and remain localized. After complete surgical removal, long-term outlook is excellent, with low chance of return. Regular follow-up helps catch rare recurrences early and addresses comfort, sexual function, and pelvic health.
Causes and risk factors
Most Bartholin's gland benign neoplasms arise sporadically. Risk may increase with chronic duct blockage, prior Bartholin cysts or abscesses, local irritation or trauma, and reproductive-age hormone exposure. No clear hereditary cause; infections, including STIs, can promote inflammation that may contribute.
Genetic influences
Genetics play little to no known role in Bartholin’s gland benign neoplasm. Most cases appear sporadic without inherited patterns. Rare familial clustering is not well established, and routine genetic testing isn’t recommended.
Diagnosis
Doctors diagnose Bartholin's gland benign neoplasm with a pelvic exam, sometimes using ultrasound or MRI. A small tissue sample (biopsy) confirms the diagnosis of Bartholin's gland benign neoplasm and rules out cancer, especially in women over 40.
Treatment and drugs
Treatment for Bartholin’s gland benign neoplasm focuses on removing or shrinking the growth and easing discomfort. Options can include warm sitz baths, drainage if there’s a cyst, marsupialization, or surgical excision; pathology review confirms it’s noncancerous. Follow-up checks monitor healing and recurrence.
Symptoms
People often notice a small, one-sided lump near the vaginal opening that rubs on clothing or feels in the way during sex or exercise. You might notice small changes at first—like a tiny bump that wasn't there before. Early symptoms of Bartholin's gland benign neoplasm are usually local, such as pressure or mild tenderness, without fever or feeling ill. Many find the lump grows slowly and stays painless unless irritated.
A small, firm bump develops near the back of one side of the vaginal opening. With a Bartholin's gland benign neoplasm, it often feels smooth and movable under the skin. Many notice it most when washing or wiping.
Swelling usually affects just one Bartholin's gland, creating slight asymmetry. You may see or feel a bulge on one side while the other side feels normal. Underwear or pads may rub on the fuller side.
You may feel a dull pressure when you sit, cycle, or cross your legs. Long walks or workouts can make the area feel more noticeable. Changing position often eases it.
Stretching or penetration can press on the lump. This may cause aching or sharp tenderness during or after sex. Using more lubrication or changing positions may help reduce friction.
How people usually first notice Bartholin's gland benign neoplasm?
People often first notice a small, painless lump near the vaginal opening on one side, which may slowly enlarge over weeks to months and feel rubbery or well-defined. A benign tumor of the Bartholin’s gland is uncommon, so many initially think it’s a simple cyst; doctors usually suspect it when a mass persists, recurs, or feels unusually firm in people over age 40. If there’s steady growth without signs of infection (no fever, redness, or significant tenderness), a clinician may recommend imaging or a biopsy to confirm the cause.
Types of Bartholin's gland benign neoplasm
Bartholin’s gland benign neoplasm is an uncommon, non-cancerous growth in one of the small glands near the vaginal opening. There aren’t distinct genetic variants defined for this condition; instead, clinicians describe types based on how the lump looks, what tissue it grows from, and how it behaves over time. Symptoms don’t always look the same for everyone. When people ask about types of Bartholin’s gland benign neoplasm, they’re usually referring to patterns like cyst-like growths, fibrous nodules, or wart-like surface changes, each with slightly different symptoms and exam findings.
Cyst-like lesion
Often feels like a soft, smooth lump near the vaginal opening that may shift slightly under the skin. It can cause pressure with sitting, cycling, or intercourse, and may swell during activity. Pain tends to be mild unless it gets irritated.
Fibrous adenoma
Presents as a firm, well-defined nodule from the gland tissue itself. Many notice a steady-size lump that’s not very tender but can cause discomfort with movement or intimacy. Doctors sometimes feel a rubbery border on exam.
Papillary growth
Looks or feels like a small, wart-like surface change at the duct opening. It may cause rubbing discomfort, spotting after intercourse, or a sensation of fullness. Bleeding is usually light and intermittent if present.
Myxoid-type lesion
Feels soft and gelatinous, sometimes fluctuating slightly in size. People may notice a squishy lump that’s less painful but annoying due to pressure or friction. These usually grow slowly and remain well-circumscribed.
Inflammation-prone type
A benign mass that tends to get irritated or inflamed after exercise, long walks, or sexual activity. Swelling and tenderness can flare for a few days, then settle. Keeping track can help you spot triggers and discuss types of Bartholin’s gland benign neoplasm with your clinician.
What genetics can tell you about symptoms
Some people with inherited variants in tumor-suppressor genes like PTEN or BRCA1/2 may develop benign Bartholin’s gland growths earlier or more often. These changes can cause a painless vulvar lump, occasional pressure or discomfort when sitting, and sometimes drainage if a cyst forms.
Causes and risk factors
The exact cause is unclear, and most tumors develop without a clear trigger. Repeated blockage or inflammation of the Bartholin’s gland duct may raise risk, especially with frequent cysts or abscesses. Risk factors for Bartholin's gland benign neoplasm seem to be mainly local issues, and these growths are found more often in adults than in teens. Genetic or family risks have not been shown, and lifestyle or environmental links remain weak or uncertain. Researchers are still learning how these pieces fit together.
Environmental and biological risk factors
Here we look at environmental and biological factors that may raise the chance of a Bartholin's gland benign neoplasm. Doctors often group risks into internal (biological) and external (environmental). This section focuses on risk, not the early symptoms of Bartholin's gland benign neoplasm. Because this condition is rare, research on precise risks is limited, so the patterns below reflect how this gland tends to respond to blockage, hormones, and inflammation.
As the gland and surrounding tissues change across the reproductive years, cells may respond more strongly to growth signals. These shifts can create conditions where a benign overgrowth is more likely.
Estrogen and progesterone influence how glandular cells grow and repair. Periods of stronger hormonal stimulation can encourage noncancerous growth in Bartholin tissue. In some, this pattern contributes to a Bartholin's gland benign neoplasm.
Repeated swelling or infection of the gland triggers ongoing repair cycles. Over time, this low-grade inflammation can promote tissue overgrowth and benign tumor formation. Past gland infections or cysts sometimes come before a Bartholin's gland benign neoplasm.
Long-standing blockage of the Bartholin duct causes fluid buildup and pressure. This mechanical stress may stimulate cells and favor benign neoplasm development. A prior duct cyst can mark this setup in people who later develop a Bartholin's gland benign neoplasm.
Genetic risk factors
Research on genetic risk factors for Bartholin's gland benign neoplasm is limited because these tumors are rare. Most appear to be sporadic growths driven by DNA changes that arise only in the gland cells themselves, not changes you inherit. Carrying a genetic change doesn’t guarantee the condition will appear.
Somatic mutations: Most cases arise from acquired DNA changes in Bartholin gland cells. These are not inherited and do not raise risk for relatives. Doctors may call these changes somatic because they occur only in the tumor cells.
No known heredity: There is no proven inherited gene that consistently increases risk for Bartholin's gland benign neoplasm. Large hereditary cancer syndromes have not been clearly linked to these benign tumors.
Family history rare: Reports of multiple relatives with Bartholin's gland benign neoplasm are extremely uncommon. At this time, having a family member with this tumor does not meaningfully change your personal risk.
Growth control genes: Benign tumors can form when local genes that guide cell growth and repair get disrupted. Studies in similar gland tumors suggest small DNA errors can act like a stuck on switch for growth, but a single driver gene has not been confirmed for this condition. Any changes identified are usually limited to the tumor tissue.
Germline testing: Because inherited risk is not established, routine germline genetic testing is usually not needed for Bartholin's gland benign neoplasm. Testing may be considered only if there are other strong personal or family patterns of tumors, guided by a genetics professional.
Recurrence not inherited: If a benign Bartholin gland tumor returns after treatment, it is typically due to residual local cells rather than a hereditary tendency. This does not imply increased genetic risk for relatives.
Lifestyle risk factors
Evidence linking habits to Bartholin's gland benign neoplasm is limited, but behaviors that promote vulvar irritation, infection, or duct blockage may influence risk or recurrence. In this context, the lifestyle risk factors for Bartholin's gland benign neoplasm focus on reducing chronic inflammation around the duct opening. Diet and exercise have no direct proven effect, but some choices can indirectly reduce moisture, friction, or infections that impact the gland.
Unprotected intercourse and multiple partners can raise the risk of STIs and vaginal infections that inflame the Bartholin duct. Recurrent inflammation and obstruction may contribute to benign gland overgrowth or related lesions.
Vaginal douching, perfumed soaps, and scented wipes can disrupt healthy flora and irritate vulvar tissue. Chronic irritation may promote duct blockage and reactive benign changes in the gland.
Tight, non-breathable underwear or leggings can increase heat, moisture, and chafing at the vestibule. This may swell the duct opening and raise the chance of obstruction and benign growths.
Smoking impairs local immune defenses and mucosal healing. Poor tissue repair can allow ongoing inflammation that may precede benign neoplastic changes in the Bartholin gland.
Risk prevention
There’s no proven way to fully prevent Bartholin's gland benign neoplasm, but you can lower chances of irritation and catch changes early. Prevention is about lowering risk, not eliminating it completely. Knowing the early symptoms of Bartholin's gland benign neoplasm—such as a small, usually painless lump near the vaginal opening—helps you seek care sooner. Routine check-ins and prompt evaluation of any new or persistent vulvar lump make the biggest difference.
Yearly check-ups help spot any Bartholin’s area changes early. Ask for an exam sooner if you notice a new lump or one that doesn’t improve in 2–4 weeks.
If you feel a persistent bump near the vaginal opening, book a visit rather than waiting. Quick assessment can rule out Bartholin's gland benign neoplasm or catch it early.
Using condoms or dental dams lowers sexually transmitted infections that can inflame the Bartholin’s gland. Less irritation may reduce the chance of gland problems over time.
Treat Bartholin cysts or abscesses quickly to limit ongoing inflammation. Reducing repeated swelling may help lower the likelihood of tissue changes in the area.
Transmission
Bartholin's gland benign neoplasm is not an infection and cannot be transmitted to anyone else. It does not spread through sexual contact, everyday touch, or shared items, and partners and family are not at risk. There is no genetic transmission of Bartholin's gland benign neoplasm; it does not typically run in families and you cannot pass it to children. In short, there is no pathway for how Bartholin's gland benign neoplasm is transmitted—it isn’t contagious.
When to test your genes
Consider genetic testing if you have multiple or recurrent Bartholin’s gland tumors, a strong family history of gynecologic or breast cancers, or early-onset cancers in close relatives. Testing generally targets hereditary cancer genes (like BRCA1/2) to guide surveillance and surgical decisions. Discuss timing with a genetics professional before any planned treatment.
Diagnosis
You might first notice a painless lump near the vaginal opening that seems slow-growing and doesn’t go away like a typical cyst or abscess. Many people feel relief just knowing what’s really going on. Doctors focus on how Bartholin's gland benign neoplasm is diagnosed by combining a careful exam with imaging and a small tissue sample when needed. The goal is to confirm it’s benign and to rule out other causes, including infection or, rarely, cancer.
Your provider asks when the lump appeared, if it changes with your cycle, and whether there’s pain or discharge. This helps separate a benign neoplasm from a cyst or infection.
A gentle vulvar and vaginal exam checks the size, firmness, and exact location of the mass. Findings can point toward a Bartholin's gland benign neoplasm versus a cyst, abscess, or other vulvar growth.
Pelvic or vulvar ultrasound uses sound waves to see whether the mass is solid or fluid-filled. A mostly solid, well-defined mass can support the diagnosis of Bartholin's gland benign neoplasm.
MRI may be used if the mass is deep, large, or not clearly defined on ultrasound. It shows the borders and nearby structures, guiding whether observation, removal, or biopsy is best.
Stages of Bartholin's gland benign neoplasm
Bartholin's gland benign neoplasm does not have defined progression stages. These benign growths usually stay localized in the gland, so care focuses on size, symptoms, and what is found on exam rather than any stage-based system. Early symptoms of Bartholin's gland benign neoplasm may include noticing a small lump or pressure at the vaginal opening, which can be tender if irritated. Doctors usually start with a conversation about symptoms and do a pelvic exam; they may add imaging or a small sample (biopsy) if anything looks unusual to confirm the diagnosis and guide follow-up.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, especially after hearing Bartholin's gland benign neoplasm during a pelvic exam or imaging. In most cases, these growths are slow-growing and noncancerous, so the long-term outlook is generally favorable. Recurrence can happen, particularly if the gland or cyst wall isn’t fully removed, but many living with a Bartholin’s gland benign neoplasm do well with minor procedures and periodic check-ins. Early care can make a real difference when it comes to comfort, infection prevention, and lowering the chance the lump returns.
When thinking about the future, it helps to know that life expectancy is not affected by a Bartholin’s gland benign neoplasm, and mortality from this condition is essentially not a concern. The main issues are local—tenderness with sitting, cycling, or intimacy; occasional swelling; and, if the duct gets blocked, a painful cyst or abscess that may need drainage. Some people experience long stretches with no symptoms, while others notice on-and-off discomfort that flares with pressure or activity. Understanding the prognosis can guide planning and help you decide between watchful waiting, office drainage, marsupialization, or complete excision if symptoms keep returning.
The outlook is not the same for everyone, but most people achieve lasting relief after the right procedure and good wound care. If you’re worried about early symptoms of Bartholin’s gland benign neoplasm—like a painless lump near the vaginal opening that becomes tender over days—prompt evaluation can prevent infection and shorten recovery time. Loved ones often play a key role in practical support after a procedure, such as rides to appointments and help with sitz baths during healing. Talk with your doctor about what your personal outlook might look like, including your recurrence risk and what to watch for over time.
Long-term effects
Bartholin's gland benign neoplasm usually has a good outlook, especially when the lump is fully removed. Long-term effects vary widely, and many people have no lasting problems after treatment. When issues do happen, they tend to be local—related to the area around the gland—rather than affecting overall health. You and your care team will mainly watch for any new changes in the same spot over time.
The lump can return in the same area, particularly if the original growth was not completely removed. If a new painless lump appears, that can mirror early symptoms of Bartholin's gland benign neoplasm.
Some feel pain with sex or pressure when sitting for long periods. This often improves over months but can linger for a few people.
Scar tissue at the vulva may cause pulling or a firm spot. The sensation can soften with healing, though a small bump may remain.
Removing one gland can slightly reduce natural moisture on that side. Most people do not notice a major change in overall comfort.
How is it to live with Bartholin's gland benign neoplasm?
Day to day, many living with a benign Bartholin’s gland tumor notice a small lump near the vaginal opening that may cause pressure, rubbing discomfort with walking, cycling, or sitting, and pain with sex or pelvic exams. Choosing softer, breathable underwear, using warm soaks, and planning activities around comfort on flare days can help, and most people can continue work, exercise, and intimacy with adjustments. Partners and family often play a role by being patient with changes in sexual activity or routines, and by offering practical support for appointments or recovery if a procedure is needed. With clear information and a care plan from a clinician, most find the condition manageable and not a barrier to a full life.
Treatment and drugs
Treatment for Bartholin’s gland benign neoplasm focuses on relieving symptoms, confirming the growth is noncancerous, and preventing it from coming back. Small, symptom-free lumps may simply be watched with regular check-ins, while painful or bothersome growths are usually treated with a minor procedure to drain or remove the cyst or tumor; your doctor may place a small catheter to keep it open while it heals or perform marsupialization to create a new drainage opening. If there’s any doubt about the diagnosis, the tissue is sent for biopsy to rule out cancer, especially in people over 40. Antibiotics are used only if there’s an infection, and pain is managed with simple pain relievers and warm sitz baths. Not every treatment works the same way for every person, so your doctor may suggest a stepwise plan—starting with the least invasive option and moving to surgical removal of the Bartholin’s gland if symptoms keep coming back.
Non-drug treatment
A small, benign lump near the vaginal opening can cause pressure, rubbing, or pain with sitting or sex. Early symptoms of Bartholin's gland benign neoplasm can be subtle, so regular monitoring matters. Non-drug treatments often lay the foundation, from watchful waiting to procedures that remove the mass. Your care team will tailor choices to the size of the lump, your symptoms, and your goals for comfort and activity.
Regular checkups and self‑monitoring can track any change in size or symptoms. This approach suits small, painless lumps and helps avoid procedures you may not need.
A small tissue sample can confirm the diagnosis and rule out other causes. Results guide whether simple monitoring or removal is the best next step for Bartholin's gland benign neoplasm.
Removing the lump through a small incision can quickly relieve pressure or pain. It is usually an outpatient procedure and aims to fully remove Bartholin's gland benign neoplasm.
When possible, surgeons remove only the lump while keeping the gland. This can lower the chance of dryness or discomfort and is decided case by case.
Your genes may have an impact on how drugs work for you
Most medicines for Bartholin’s gland benign neoplasms aren’t directly tailored by genes, but your genetic makeup can affect how you process pain relievers, antibiotics, or anesthesia used around treatment. Variants in liver enzyme genes can change dose needs and side‑effect risks.
Pharmacological treatments
Day-to-day, medicines for Bartholin's gland benign neoplasm mainly ease discomfort and support healing around procedures, since the core treatment is often surgical. Drugs that target symptoms directly are called symptomatic treatments. For early symptoms of Bartholin's gland benign neoplasm like tenderness or swelling, simple pain relief can help while you and your clinician decide on next steps. Antibiotics are only used if there’s an abscess or proven infection, or if a sexually transmitted infection is found.
Ibuprofen or naproxen can reduce pain and swelling; acetaminophen is a good option if you can’t take anti-inflammatories. These are usually taken for short periods during flares or after procedures.
Lidocaine injection or gel is used to numb the area for drainage, marsupialization, or excision. It acts quickly and wears off within a few hours.
Amoxicillin–clavulanate, trimethoprim–sulfamethoxazole, or doxycycline may be prescribed if there’s an abscess or signs of bacterial infection. Metronidazole may be added when anaerobic coverage is needed, such as with foul-smelling drainage.
Ceftriaxone (injection) is used for gonorrhea and doxycycline for chlamydia when testing indicates these infections. Treating STIs helps the gland recover and can lower the risk of a recurrent abscess in Bartholin's gland benign neoplasm.
Genetic influences
For Bartholin's gland benign neoplasm, inherited or family genetic factors don’t seem to play a major role; most cases happen sporadically without a clear hereditary pattern. It’s natural to ask whether family history plays a role. The growth itself may carry gene changes that arise only in the gland’s cells as the tumor forms, but these are local changes and aren’t passed down to children. Because of this, routine genetic testing for Bartholin's gland benign neoplasm isn’t recommended, and results rarely change treatment or follow-up. If several close relatives have had unusual or early cancers, or if you’ve had multiple rare tumors, your doctor may still suggest a broader genetics review to look at overall cancer risk, but that evaluation isn’t specific to Bartholin's gland benign neoplasm.
Is Bartholin's gland benign neoplasm genetic?
Genetics play little to no known role in Bartholin’s gland benign neoplasm. Most cases appear sporadic without inherited patterns. Rare familial clustering is not well established, and routine genetic testing isn’t recommended.
Pharmacogenetics—how genetics influence drug effects
Treatment for Bartholin's gland benign neoplasm often centers on a minor procedure or surgery, with short-term pain relief and, if needed, antibiotics. Genes can influence how quickly you break down certain pain medicines. For example, some people don’t convert codeine or tramadol into their active form well and get limited pain relief, while others convert them very quickly and may feel side effects at usual doses. If a sulfa antibiotic is used after the procedure, a known G6PD deficiency raises the risk of red blood cell breakdown, so your team may choose a different option. Genetics can also affect anesthesia safety—rare inherited traits like malignant hyperthermia make certain anesthetic drugs unsafe, so sharing any family history of anesthesia problems helps your clinicians plan. At present, there is no tumor-specific genetic testing that directs the surgery or medicine choice for Bartholin's gland benign neoplasm, and pharmacogenetic testing for Bartholin's gland benign neoplasm isn’t routinely recommended; decisions are guided mainly by your symptoms, exam findings, and recovery goals.
Interactions with other conditions
Swelling from a Bartholin's gland benign neoplasm can sometimes narrow or block the gland’s duct, which raises the chance of a cyst or even an abscess forming in the same area. Having more than one diagnosis can make symptoms feel harder to untangle. If an abscess occurs alongside the neoplasm, pain, redness, and fever may be more intense, and treatment often focuses on controlling infection first before addressing the lump itself.
Other health issues can shape recovery and care. People living with diabetes or those taking immune‑suppressing medicines may face a higher risk of infection and slower wound healing after procedures for Bartholin's gland benign neoplasm, so doctors may adjust antibiotics, timing, and follow‑up. In those over 40, similar‑looking lumps can rarely be cancer, and coexisting vulvar skin conditions can add irritation or itching, which can make early symptoms of Bartholin's gland benign neoplasm easy to overlook. It’s worth asking how your other conditions or medicines might change the procedure plan and pain control, including whether any treatments for infection could interact with your current prescriptions.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described tender swellings near the vaginal opening that sometimes drained on their own and sometimes needed lancing by a midwife or surgeon. Before modern pathology, these lumps were grouped together as “Bartholin cysts” or abscesses. Only later did doctors learn that a small share are growths made of the gland’s own tissue, now understood as Bartholin’s gland benign neoplasm.
From early theories to modern research, the story of Bartholin’s gland benign neoplasm reflects how tools changed the diagnosis. In the 19th and early 20th centuries, descriptions focused on pain, fever, or difficulty sitting and walking, because that’s what people felt and what clinicians could see. Microscopes improved, surgical specimens were examined, and patterns emerged: most Bartholin swellings were blocked ducts or infections, but a minority were true tumors that did not invade nearby tissue.
Initially understood only through symptoms, later cases were sorted by what they looked like under the microscope. This shift mattered. It helped separate harmless, fluid-filled cysts from benign neoplasms, and both from rare cancers of the Bartholin gland. As outpatient gynecology expanded in the mid-20th century, surgeons published case series, noting that benign tumors were uncommon, usually slow-growing, and often found incidentally during surgery for a presumed cyst.
In recent decades, awareness has grown that age and exam features guide decisions. Many living with a new Bartholin lump in their teens, 20s, or 30s are found to have a cyst or abscess, while new masses after menopause raise the threshold for biopsy to rule out malignancy. That careful approach also clarified the place of Bartholin’s gland benign neoplasm: uncommon, typically well-circumscribed growths confirmed after removal.
Pathology techniques continued to refine the picture. Stains and imaging at the cellular level allowed pathologists to label subtypes and confirm that these tumors, while enlarged, lacked the aggressive behavior of cancer. Surgical methods shifted as well—from routine marsupialization used for cysts to complete excision when a solid mass suggested a neoplasm—leaving clearer tissue for diagnosis and better long‑term follow‑up data.
Over time, the way the condition has been understood has changed, but the practical message for patients stayed steady: most Bartholin lumps are benign; a small number are benign neoplasms; and an even smaller number are cancers. Today’s guidance—exam, age-aware assessment, and biopsy or removal when features are atypical—grew directly from that history. Knowing the condition’s history helps explain why clinicians recommend tissue diagnosis for certain Bartholin masses and why, once a benign neoplasm is confirmed, reassurance about its low risk and discussion of complete removal are standard.